CELLECTIS - ADR (CLLS) Stock Price, Quote, News and Overview

What is the stock price of CELLECTIS - ADR today?

The current stock price of CLLS is 1.498 USD. The price decreased by -2.09% in the last trading session.

What is the ticker symbol for CELLECTIS - ADR stock?

The exchange symbol of CELLECTIS - ADR is CLLS and it is listed on the Nasdaq exchange.

On which exchange is CLLS stock listed?

CLLS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for CELLECTIS - ADR stock?

13 analysts have analysed CLLS and the average price target is 5.61 USD. This implies a price increase of 274.23% is expected in the next year compared to the current price of 1.498. Check the CELLECTIS - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is CELLECTIS - ADR worth?

CELLECTIS - ADR (CLLS) has a market capitalization of 149.94M USD. This makes CLLS a Micro Cap stock.

How many employees does CELLECTIS - ADR have?

CELLECTIS - ADR (CLLS) currently has 219 employees.

What are the support and resistance levels for CELLECTIS - ADR (CLLS) stock?

CELLECTIS - ADR (CLLS) has a support level at 1.5 and a resistance level at 1.53. Check the full technical report for a detailed analysis of CLLS support and resistance levels.

Is CELLECTIS - ADR (CLLS) expected to grow?

The Revenue of CELLECTIS - ADR (CLLS) is expected to grow by 169.93% in the next year. Check the estimates tab for more information on the CLLS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy CELLECTIS - ADR (CLLS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CLLS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CLLS, evaluating the profitability, health, valuation and growth aspects
• CELLECTIS - ADR (CLLS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• CELLECTIS - ADR (CLLS) Sales and EPS estimates to see what analysts future expectations are.
• CELLECTIS - ADR (CLLS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• CELLECTIS - ADR (CLLS) Insider and Institutional Ownership to learn about the owners and their transactions.
• CELLECTIS - ADR (CLLS) Stock Chart to make your own analysis
• CELLECTIS - ADR (CLLS) Latest news and press-releases to stay up to date.

Does CELLECTIS - ADR (CLLS) stock pay dividends?

CLLS does not pay a dividend.

When does CELLECTIS - ADR (CLLS) report earnings?

CELLECTIS - ADR (CLLS) will report earnings on 2025-04-28, after the market close.

What is the Price/Earnings (PE) ratio of CELLECTIS - ADR (CLLS)?

CELLECTIS - ADR (CLLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.13).

What is the Short Interest ratio of CELLECTIS - ADR (CLLS) stock?

The outstanding short interest for CELLECTIS - ADR (CLLS) is 0.3% of its float. Check the ownership tab for more information on the CLLS short interest.

ChartMill assigns a fundamental rating of 3 / 10 to CLLS. CLLS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months CLLS reported a non-GAAP Earnings per Share(EPS) of -1.13. The EPS increased by 32.35% compared to the year before.

ChartMill assigns a Buy % Consensus number of 86% to CLLS. The Buy consensus is the average rating of analysts ratings from 13 analysts.

For the next year, analysts expect an EPS growth of 60.81% and a revenue growth 169.93% for CLLS